Journal of Antimicrobial Chemotherapy (1999) 44, 141-144
© 1999 The British Society for Antimicrobial Chemotherapy
Leading article |
Penicillin-resistant Streptococcus pneumoniae: selection by both ß-lactam and non-ß-lactam antibiotics
Laboratoire de Microbiologie Médicale, Fondation Hôpital Saint-Joseph, 185 rue Raymond Losserand, 75674 Paris Cédex 14, France
In recent years there has been a dramatic increase, worldwide, in the prevalence of so-called penicillin-resistant Streptococcus pneumoniae (PRSP);1 in some European countries and certain regions of the USA, South America and South East Asia, prevalences currently exceed 40–50%. The overall increase has been attributed to excessive global usage of antibiotics, particularly ß-lactams, and, in an attempt to address this problem, it has been proposed that prescribing of these drugs should be reduced or avoided altogether. Clearly such an initiative is impractical in those clinical settings in which ß-lactams are considered essential therapeutic agents. The more realistic strategy continues to be identification of those patients who require antibiotics and prescription of the most active compound at the optimal dosage for the optimal duration. Insofar as it is possible, the drug chosen should also have a low propensity for selecting resistant strains.
PRSP strains may be selected either at the site
Acknowledgments
Notes
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Garcia-Rey, A. Fenoll, L. Aguilar, and J. Casal Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain J. Antimicrob. Chemother., August 1, 2004; 54(2): 465 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Kitzis, A. Ly, and F. W. Goldstein In Vitro Activities of Tigecycline (GAR-936) against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae Antimicrob. Agents Chemother., January 1, 2004; 48(1): 366 - 367. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and R. Dal-Re Importance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae J. Clin. Microbiol., January 1, 2002; 40(1): 159 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Ho, R. W. H. Yung, D. N. C. Tsang, T. L. Que, M. Ho, W. H. Seto, T. K. Ng, W. C. Yam, and W. W. S. Ng Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000 J. Antimicrob. Chemother., November 1, 2001; 48(5): 659 - 665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Dancer The problem with cephalosporins J. Antimicrob. Chemother., October 1, 2001; 48(4): 463 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. de Neeling, B. P. Overbeek, A. M. Horrevorts, E. E. J. Ligtvoet, and W. G. Goettsch Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999 J. Antimicrob. Chemother., September 1, 2001; 48(3): 441 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K STEELE, G GORMLEY, and C H WEBB Management of adult lower respiratory tract infection in primary care Thorax, February 1, 2001; 56(2): 87 - 88. [Full Text]
|
|
|
|
 |
|
 N. L. S. Lee, K. Y. Yuen, and C. R. Kumana {beta}-Lactam Antibiotic and {beta}-Lactamase Inhibitor Combinations JAMA, January 24, 2001; 285(4): 386 - 388. [Full Text] [PDF]
|
|
|
|
|
|
A. Marchese, E. A. Debbia, and G. C. Schito Comparative in vitro potency of gemifloxacin against European respiratory tract pathogens isolated in the Alexander Project J. Antimicrob. Chemother., July 1, 2000; 46(90003): 11 - 15. [Abstract] [Full Text]
|
|